ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 74% specificity

(Source: Yahoo Finance) Furthermore, the ProLung Test is the only predictive analytic utilizing bioconductance in lung cancer. These trial results, along with the results of a soon to be …